NASDAQ:VECT VectivBio (VECT) Stock Price, News & Analysis $16.85 0.00 (0.00%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$16.85▼$16.8550-Day Range$16.85▼$16.8552-Week Range$4.25▼$16.98VolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsTrendsStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsTrends Get VectivBio alerts: Email Address Ad Unstoppable Prosperity“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.You can find out what they are by clicking here now. About VectivBio Stock (NASDAQ:VECT)VectivBio Holding AG, a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for treatments of severe rare conditions. It develops apraglutide, a long-acting synthetic peptide analog of glucagon-like peptide-2 that is in Phase III clinical trial for the treatment of patients with short bowel syndrome-intestinal failure (SBS-IF), as well as apraglutide is in Phase II clinical trial for SBS-IF in patients with colon-in-continuity anatomy. The company is also developing apraglutide, which is in Phase II clinical trial for patients with steroid-refractory gastrointestinal acute versus host disease (aGvHD). VectivBio Holding AG was incorporated in 2019 and is headquartered in Basel, Switzerland. As of June 29, 2023, VectivBio Holding AG operates as a subsidiary of Ironwood Pharmaceuticals, Inc.Read More VECT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart VECT Stock News HeadlinesJuly 18, 2024 | americanbankingnews.comAnalyzing VectivBio (NASDAQ:VECT) & Qiagen (NYSE:QGEN)May 29, 2024 | msn.comCompare with VectivBio Holding AG (VECT)July 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.May 15, 2024 | finance.yahoo.comenGene Announces the Election of Paul Hastings and Wouter Joustra to its Board of DirectorsMay 14, 2024 | finanznachrichten.deVicore Pharma Holding: Vicore Expands and Strengthens its Board of DirectorsMay 14, 2024 | finance.yahoo.comVicore Expands and Strengthens its Board of DirectorsApril 5, 2024 | uk.finance.yahoo.comShort Bowel Syndrome Market by 2032: Forecast Report Estimates Significant GrowthMarch 18, 2024 | msn.comPipeline moves: Approval prospects for SBS candidate rise after Phase III trial meets endpointsJuly 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.March 1, 2024 | msn.comUPDATE 3-Ironwood's bowel disease drug meets main goal of late-stage studyFebruary 29, 2024 | reuters.comIronwood's bowel disease treatment meets main goal in late-stage trialFebruary 29, 2024 | benzinga.comWhy Is Gastrointestinal Healthcare Focused Ironwood Pharmaceuticals Stock Sinking On Thursday?February 29, 2024 | ft.comOnly two sleeps left until February 31!February 22, 2024 | finance.yahoo.comShort Bowel Syndrome Market Size and Share is Anticipated to Surge During the Study Period (2020–2034) | DelveInsightFebruary 16, 2024 | finance.yahoo.comIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q4 2023 Earnings Call TranscriptDecember 13, 2023 | msn.comIronwood seals the deal on VectivBio mergerDecember 12, 2023 | finance.yahoo.comIronwood Announces the Completion of Squeeze-Out Merger With VectivBioNovember 15, 2023 | tmcnet.comReverb Therapeutics Debuts Its Amplifier™ Platform for Redirecting Endogenous CytokinesSee More Headlines Receive VECT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for VectivBio and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today7/26/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biological products, except diagnostic Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:VECT CUSIPN/A CIK1836379 Webvectivbio.com Phone41-61-551-3030FaxN/AEmployees30Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$27.34 million Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$6.27 per share Price / Book2.69Miscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNo Data BetaN/A These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesDr. Luca Santarelli M.D. (Age 53)Founder, CEO & Director Ms. Claudia D'Augusta Ph.D. (Age 53)Chief Financial Officer Dr. Christian Meyer M.D. (Age 56)Ph.D., Chief Operating Officer Dr. Alain Bernard Ph.D. (Age 66)Chief Technology Officer Mr. Patrick MalloySr. VP of Investor Relations & Strategic CommunicationsMr. Scott Applebaum (Age 56)Chief Legal Officer & Corp. Sec. Mr. Michael SteiningerSr. VP & Head of HRMr. Kevin Harris M.B.A. (Age 52)Chief Commercial Officer Dr. Sarah Holland Ph.D. (Age 60)Chief Bus. Officer Dr. Omar Khwaja M.D. (Age 53)Ph.D., Chief Medical Officer More ExecutivesKey CompetitorsProtagonist TherapeuticsNASDAQ:PTGXDeciphera PharmaceuticalsNASDAQ:DCPHCatalyst PharmaceuticalsNASDAQ:CPRXArvinasNASDAQ:ARVNRecursion PharmaceuticalsNASDAQ:RXRXView All Competitors VECT Stock Analysis - Frequently Asked Questions How have VECT shares performed this year? VectivBio's stock was trading at $16.85 at the beginning of 2024. Since then, VECT stock has increased by 0.0% and is now trading at $16.85. View the best growth stocks for 2024 here. When did VectivBio IPO? VectivBio (VECT) raised $128 million in an initial public offering (IPO) on Friday, April 9th 2021. The company issued 7,500,000 shares at $16.00-$18.00 per share. BofA Securities, SVB Leerink and Credit Suisse served as the underwriters for the IPO and LifeSci Capital was co-manager. How do I buy shares of VectivBio? Shares of VECT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:VECT) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VectivBio Holding AG Please log in to your account or sign up in order to add this asset to your watchlist. Share VectivBio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.